IPO / listing 📈 Stocks 🌍 United States

Oura Targets $2.2 Billion IPO Valuation of $15.62 Billion on Nasdaq

Oura sets terms for a $2.2 billion Nasdaq IPO, backed by interest from Eli Lilly and Dragoneer, despite ongoing legal challenges regarding product claims.

📅 September 21, 2026 🕐 1 min read

2 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 2 Neutral. Strongest signal: OURA → 7/10 (65% confidence).

📊 Affected Assets (2)

OURA

Neutral 🤖 65%

📅 Short-term 🌍 US · Explicit

Oura launches its IPO to raise up to $2.2 billion, listing on Nasdaq under OURA, with strong revenue growth but facing a class-action lawsuit.

LLY

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

Eli Lilly signals potential purchase of up to $100 million of Oura shares in the IPO.

🎯 Key Takeaways

Oura is offering 50 million shares at a price range of $40 to $44 per share.
Eli Lilly and Dragoneer have signaled interest in purchasing $100 million and $300 million of shares, respectively.
Revenue grew 74% year-over-year to $1.21 billion, with the company projecting 5.7 million paid members by fiscal 2026.
The company faces a pending class-action lawsuit alleging misleading marketing regarding sleep-tracking accuracy.

📝 Executive Summary

Wearable tech firm Oura has launched its IPO, aiming to raise up to $2.2 billion at a $15.62 billion valuation. The company reported a 74% revenue surge to $1.21 billion for the nine months ending June 30, even as it faces a class-action lawsuit regarding the accuracy of its sleep-tracking technology.

❓ FAQ

What is the ticker symbol for Oura's upcoming IPO?

Oura has applied to list on the Nasdaq Global Select Market under the ticker symbol OURA.

How does the current IPO valuation compare to Oura's previous funding round?

The IPO targets a valuation of $15.62 billion, an increase from the $11 billion valuation reached during a $900 million funding round in October.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article